OliX Pharmaceuticals Statistics

Total Valuation

KOSDAQ:226950 has a market cap or net worth of KRW 2.41 trillion. The enterprise value is 2.30 trillion.

Market Cap	2.41T
Enterprise Value	2.30T

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:226950 has 20.11 million shares outstanding. The number of shares has increased by 15.15% in one year.

Current Share Class	20.11M
Shares Outstanding	20.11M
Shares Change (YoY)	+15.15%
Shares Change (QoQ)	+1.10%
Owned by Insiders (%)	17.49%
Owned by Institutions (%)	15.21%
Float	16.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	236.28
PB Ratio	16.88
P/TBV Ratio	17.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-53.10
EV / Sales	225.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-146.62

Financial Position

The company has a current ratio of 7.61, with a Debt / Equity ratio of 0.16.

Current Ratio	7.61
Quick Ratio	7.51
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-1.48
Interest Coverage	-9.70

Financial Efficiency

Return on equity (ROE) is -54.34% and return on invested capital (ROIC) is -15.76%.

Return on Equity (ROE)	-54.34%
Return on Assets (ROA)	-13.47%
Return on Invested Capital (ROIC)	-15.76%
Return on Capital Employed (ROCE)	-17.23%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.08
Inventory Turnover	0.49

Taxes

In the past 12 months, KOSDAQ:226950 has paid 2.42 billion in taxes.

Income Tax	2.42B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +374.60% in the last 52 weeks. The beta is 0.51, so KOSDAQ:226950's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	+374.60%
50-Day Moving Average	112,508.00
200-Day Moving Average	65,945.50
Relative Strength Index (RSI)	47.29
Average Volume (20 Days)	989,327

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:226950 had revenue of KRW 10.18 billion and -43.30 billion in losses. Loss per share was -2,279.99.

Revenue	10.18B
Gross Profit	9.88B
Operating Income	-29.12B
Pretax Income	-40.88B
Net Income	-43.30B
EBITDA	-26.61B
EBIT	-29.12B
Loss Per Share	-2,279.99

Full Income Statement

Balance Sheet

The company has 131.46 billion in cash and 23.15 billion in debt, giving a net cash position of 108.30 billion or 5,384.30 per share.

Cash & Cash Equivalents	131.46B
Total Debt	23.15B
Net Cash	108.30B
Net Cash Per Share	5,384.30
Equity (Book Value)	142.56B
Book Value Per Share	7,040.71
Working Capital	116.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.89 billion and capital expenditures -3.79 billion, giving a free cash flow of -15.68 billion.

Operating Cash Flow	-11.89B
Capital Expenditures	-3.79B
Free Cash Flow	-15.68B
FCF Per Share	-779.56

Full Cash Flow Statement

Margins

Gross Margin	97.08%
Operating Margin	-286.04%
Pretax Margin	-401.48%
Profit Margin	n/a
EBITDA Margin	-261.35%
EBIT Margin	-286.04%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:226950 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.15%
Shareholder Yield	-15.15%
Earnings Yield	-1.80%
FCF Yield	-0.65%

Stock Splits

The last stock split was on December 3, 2020. It was a forward split with a ratio of 2.

Last Split Date	Dec 3, 2020
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:226950 has an Altman Z-Score of 9.61 and a Piotroski F-Score of 3.

Altman Z-Score	9.61
Piotroski F-Score	3